ALiA

ALiA BioTech Holding is a developer of high-performance NGS targeted enrichment workflows for cancer research. ALiA BioTech is a company that provides accurate and actionable diagnostic information through our Point-of-Care Testing (POCT) platform and BioChip, enabling professionals and frontline staff to make faster clinical decisions and achieve better economic outcomes. ALiA BioTech Holding was established with the sole purpose of simplifying how we address diseases, driving innovation to shape the future of disease diagnosis.